Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.5130
+0.0020 (0.39%)
At close: Feb 6, 2026, 4:00 PM EST
0.5130
0.00 (0.00%)
After-hours: Feb 6, 2026, 5:31 PM EST
Longeveron Market Cap
Longeveron has a market cap or net worth of $10.94 million as of February 6, 2026. Its market cap has decreased by -57.12% in one year.
Market Cap
10.94M
Enterprise Value
2.64M
1-Year Change
-57.12%
Ranking
Category
Stock Price
$0.51
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $10.94M, a decrease of -93.66%. That is a compound annual growth rate of -42.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 10.90M | 0.99% |
| Dec 31, 2025 | 10.79M | -57.95% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | 172.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioAtla | 12.17M |
| CollPlant Biotechnologies | 12.16M |
| Hoth Therapeutics | 12.03M |
| CytoMed Therapeutics | 11.66M |
| Tempest Therapeutics | 11.58M |
| Soligenix | 11.28M |
| Sensei Biotherapeutics | 10.98M |
| Bolt Biotherapeutics | 10.56M |